GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Accumulated other comprehensive income (loss)

Sansure Biotech (SHSE:688289) Accumulated other comprehensive income (loss) : ¥0 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Sansure Biotech's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was ¥0 Mil.

Sansure Biotech Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Sansure Biotech's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Accumulated other comprehensive income (loss) Chart

Sansure Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial - - - - -

Sansure Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sansure Biotech Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Sansure Biotech Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
SHSE:688029 SZSE:300595 SZSE:300573 SZSE:300171 SZSE:301101 SHSE:688050 SZSE:300677 SZSE:300061 SZSE:301367 SHSE:688151 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Website
http://www.sansure.com.cn
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Executives
Tan De Yong Core technical personnel
Wang Hai Xiao senior management
Jie Ya Ping Core technical personnel
Zhang Ke Ya Core technical personnel
Yang Li Core technical personnel
Liu Rang Jiao Core technical personnel
Deng Zhong Ping Senior management, core technical personnel
Zhou Jun senior management
Zhu Jian senior management
Wu Kang Core technical personnel
Xiong Xiao Yan senior management
Ji Bo Zhi Core technical personnel
Mou Wei Min Core technical personnel
Ren Xiao Mei Core technical personnel
Liu Kai senior management

Sansure Biotech Headlines

No Headlines